iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
/PRNewswire/ -- iQure Pharma Inc. (iQure), a Princeton-based global biotech company, today confirmed completion of Early Closing as part of its Series A...
Source: prnewswire.com